Volume 61, Issue 5, Pages (May 2002)

Slides:

Advertisements

Similar presentations

Management of IgA nephropathy: Evidence-based recommendations

Advertisements

Volume 69, Issue 5, Pages (March 2006)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson

Adhesion molecule polymorphisms in chronic renal allograft failure

Progression of renal failure and hypertensive nephrosclerosis

G protein β3 subunit C825T polymorphism in primary IgA nephropathy

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Volume 56, Issue 2, Pages (August 1999)

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Steven J. Chadban, Natalie D. Staplin Kidney International

Volume 65, Issue 1, Pages (January 2004)

Volume 58, Issue 5, Pages (November 2000)

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

Volume 68, Issue 1, Pages (July 2005)

Volume 71, Issue 11, Pages (June 2007)

The genetic susceptibility to IgA nephropathy: A novel functional candidate gene for incomplete O-glycosylation of IgA1 I. Narita, Y. Kaneko, D. Kondo,

Volume 60, Issue 5, Pages (November 2001)

Acute myocardial infarction in patients with end-stage renal disease

Volume 76, Issue 5, Pages (September 2009)

Obesity-related glomerulopathy: An emerging epidemic

Volume 59, Issue 2, Pages (February 2001)

Locking of tunneled hemodialysis catheters with gentamicin and heparin

Acute Kidney Injury Increases Mortality After Lung Transplantation

Volume 61, Issue 1, Pages (January 2002)

Should kidney donors be genotyped for APOL1 risk alleles?

Volume 89, Issue 5, Pages (May 2016)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 61, Issue 2, Pages (February 2002)

Volume 65, Issue 4, Pages (April 2004)

IgA nephropathy at two score and one

Counteracting progression of renal disease: A look into the future

Volume 68, Issue 2, Pages (August 2005)

Volume 69, Issue 8, Pages (April 2006)

Volume 67, Issue 5, Pages (May 2005)

Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,

Volume 67, Issue 3, Pages (March 2005)

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Volume 82, Issue 7, Pages (October 2012)

Volume 69, Issue 9, Pages (May 2006)

Volume 73, Issue 9, Pages (May 2008)

Volume 63, Issue 2, Pages (February 2003)

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant Chirag R. Parikh, Peter Mcsweeney,

Stephen P. Mcdonald, Graeme R. Russ Kidney International

The Danish Renal Biopsy Register

Volume 63, Issue 3, Pages (March 2003)

Glucose transporter (GLUT1) allele (XbaI–) associated with nephropathy in non-insulin- dependent diabetes mellitus Zhi-Hong Liu, Tian-Jun Guan, Zhao-Hong.

Is it the low-protein diet or simply the salt restriction?

Volume 69, Issue 10, Pages (May 2006)

Treatment of the primary hyperoxalurias: A new chapter

Volume 64, Issue 4, Pages (October 2003)

Charles A. Herzog Kidney International

Volume 62, Issue 5, Pages (November 2002)

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Volume 55, Issue 2, Pages (February 1999)

Volume 64, Issue 4, Pages (October 2003)

Membranous nephropathy: recent travels and new roads ahead

Volume 64, Issue 3, Pages (September 2003)

Ivan D. Maya, Michael Allon Kidney International

Volume 80, Issue 9, Pages (November 2011)

Prediction in idiopathic membranous nephropathy

Kidney and hypertension

Volume 60, Issue 2, Pages (August 2001)

Volume 57, Pages S44-S48 (April 2000)

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 61, Issue 5, Pages 1853-1858 (May 2002) Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients Ichiei Narita, M.D., Noriko Saito, Shin Goto, Song Jin, Kentaro Omori, Minoru Sakatsume, Fumitake Gejyo Kidney International Volume 61, Issue 5, Pages 1853-1858 (May 2002) DOI: 10.1046/j.1523-1755.2002.00336.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Renal survival in IgA nephropathy patients with the GG (dashed line;N = 87) and with AG/AA genotypes (solid line; N = 152) of uteroglobin G38A polymorphism. Kaplan-Meier, log rank test, P = 0.059. Kidney International 2002 61, 1853-1858DOI: (10.1046/j.1523-1755.2002.00336.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Renal survival in IgA nephropathy patients with (A, Kaplan-Meier, log rank test,P = 0.038) and without (B, Kaplan-Meier, log rank test,P = 0.790) hypertension at the time of renal biopsy. Symbols are: (dotted line) GG genotype; (solid line) AG/AA genotype. In hypertensive patients (A), N = 49 GG genotype and 48 AG/AA genotype. In IgA nephropathy patients without hypertension (B), N = 38 GG genotype and 104 AG/AA genotype. Kidney International 2002 61, 1853-1858DOI: (10.1046/j.1523-1755.2002.00336.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Renal survival in IgA nephropathy patients with (A, Kaplan-Meier, log rank test,P = 0.014) and without (B, Kaplan-Meier, log rank test,P = 0.903) a proteinuria level of more than 2 g/day at the time of renal biopsy. Symbols are: (dotted line) GG genotype; (solid line) AG/AA genotype. In the patients with>2 g/day proteinuria (A), N = 29 GG genotype and 49 AG/AA genotype. In patients with ≤2 g/day proteinuria (B), N = 58 GG genotype and 103 AG/AA genotype. Kidney International 2002 61, 1853-1858DOI: (10.1046/j.1523-1755.2002.00336.x) Copyright © 2002 International Society of Nephrology Terms and Conditions